Vernieri, Fabrizio http://orcid.org/0000-0002-9594-9336
Iannone, Luigi Francesco
Guerzoni, Simona
Russo, Antonio
Barbanti, Piero
Sances, Grazia
Cevoli, Sabina
Rao, Renata
Lovati, Carlo
Ambrosini, Anna
Buzzoni, Carlotta
Battisti, Federico
Vatteone, Laura
King, Steffy Martin Luther
Torelli, Federico
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 21 October 2023
Accepted: 15 January 2024
First Online: 8 February 2024
Declarations
:
: Fabrizio Vernieri received travel grants, honoraria for advisory boards, speaker panels, or clinical investigation studies from Allergan/Abbvie, Amgen, Angelini, Lilly, Lundbeck, Novartis, and Teva. Luigi Francesco Iannone received consulting fees form Eli-Lilly and TEVA, payment or honoraria for lectures/presentations/speaker’s bureaus/educational events from Eli-Lilly, TEVA, and Pfizer, and support for attending meetings from Lundbeck. Simona Guerzoni received travel grants, honoraria for advisory boards, speaker panels, or clinical investigation studies from Eli-Lilly, TEVA, Pfizer, and Lundbeck. Antonio Russo reports honoraria for lectures, educational events or speaker’s bureaus and support for meeting attendance and travel from, as well as advisory board membership with Novartis, Teva, Eli Lilly and Company, Allergan/Abbvie and membership of the Board of Trustee of the Italian Headache Society. Piero Barbanti received travel grants, honoraria for advisory boards, speaker panels, research support and/or clinical investigation study support from Abbvie, Alder, Allergan, Amgen, Angelini, Assosalute, Bayer, Biohaven, electroCore, Eli Lilly, Fondazione Ricerca e Salute, GSK, Lundbeck, Lusofarmaco, 1MED, MSD, New Penta, Noema Pharma, Novartis, STX-Med, Teva, Visufarma, and Zambon, and serves as President of the Italian Neurological Association for Headache Research. Grazia Sances received travel grants, honoraria for advisory boards, speaker panels, or clinical investigation studies from Novartis, Eli Lilly, TEVA, Lundbeck, and Pfizer. Sabina Cevoli received travel grants, honoraria for advisory boards, speaker panels, and/or clinical investigation studies from Novartis, Eli Lilly, TEVA, Lundbeck, and BHV. Renata Rao received honoraria for travel grants and honoraria for advisory boards and speaker panels from Novartis, Lillly, Teva, Allergan, Lundbeck. Carlo Lovati received travel grants, honoraria for advisory boards and speaker panels, and/or clinical investigation studies from Novartis, Eli Lilly, Abbvie, Laborest, and Cristalpharma srl. Anna Ambrosini received travel grants, honoraria for advisory boards, speaker panels, or clinical investigation studies from Novartis, Eli Lilly, TEVA and Pfizer. Carlotta Buzzoni, Federico Battisti, Laura Vatteone, and Federico Torelli are employees and minor shareholders of Eli Lilly Company.
: The study was conducted based on the guidelines outlined in Strengthening the Reporting of Observational Studies in Epidemiology (STROBE), in accordance with the Declaration of Helsinki of 1964 and its later amendments, Good Pharmacoepidemiology Practices (GPPs), and the regulatory guidelines of the Italian Medicines Agency (Agenzia Italiana del Farmaco [AIFA]). The study protocol was approved by the Ethical Review Board of the local committee of each participating site (including Comitato Etico dell’Universita Campus Bio-Medico Di Roma, Comitato Etico Fondazione IRCCS Policlinico San Matteo Pavia, Comitato Etico di Area Vasta Emilia Centro CE-AVEC, Comitato Etico dell’Area Vasta Emilia Nord, Comitato Etico Regione Toscana-Area Vasta Centro c/o Azienda Ospedaliero-Universitaria Careggi, Comitato Etico della Provincia di Brescia, Comitato Etico IRCSS San Raffaele Roma, Comitato Etico Universita’ Vanvitelli Di Napoli, Comitato Etico I.N.M. Neuromed, and Comitato Etico Milano Area 1 c/o ASST FBF Sacco- P.O.L. Sacco). Written informed consent was obtained from each participant before inclusion in the study. Consent was also obtained for the use of the participant’s personal data for scientific publications in a strictly anonymous and/or aggregated format.